homologous recombination deficiency
Roche Prepping Fully Automated Comprehensive Genomic Profiling Sequencing Kit for Q1 2025 Launch
Premium
At the AMP annual meeting, Roche previewed the Avenio Tumor Tissue CGP Automated Kit, which runs on the Illumina NovaSeq 6000 and features a new pan-tumor HRD signature score.
Illumina to Incorporate Myriad's Genomic Instability Score Into Updated TSO 500 Cancer Assay
GIS measures DNA repair defects via loss of heterozygosity, large-scale state transition, and telomere allele imbalance.
Myriad Genetics, GSK Collaborate on International Ovarian Cancer Testing Program
GSK will provide financial support for a program to expand access to Myriad's MyChoice tests for patients with high-grade serous ovarian cancer.
Qiagen, Myriad Genetics to Develop Sequencing-Based Homologous Recombination Deficiency Kit
Qiagen will develop and distribute a next-generation sequencing kit-based HRD test outside the US based on Myriad's MyChoice CDx biomarkers.
Investigators affiliated with Friends of Cancer Research reported progress in assay concordance projects and discussed evolving aspects of lab test regulation at an update meeting.